Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series
Turkish Journal of Internal Medicine · 2022
DOI: 10.46310/tjim.1009709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Internal Medicine, 2022. Verfasst von Deniz İNCAMAN. Die Arbeit nennt 13 Literaturangaben. Gefördert von: yok.
Abstract (Originalsprache)
Severe thrombocytopenia is a cause of morbidity and mortality for patients with COVID-19 infection. The common causes of thrombocytopenia in these patients are; sepsis, drug-associated, disseminated intravascular coagulation (DIC), heparin-associated thrombocytopenia (HIT), microangiopathic hemolytic anemia (MAHA). Recently, cases of COVID-19 infection-associated Immune thrombocytopenic purpura (ITP) have been reported in the literature. In our study, we will present our case series consisting of 10 patients associated with COVID-19
Förderung
- yok
Zitieren
APA
İNCAMAN, D. (2022). Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series. Turkish Journal of Internal Medicine. https://doi.org/10.46310/tjim.1009709
Vancouver
İNCAMAN D. Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series. Turkish Journal of Internal Medicine. 2022. doi:10.46310/tjim.1009709
BibTeX
@article{NCAMAN2022,
author = {İNCAMAN, Deniz},
title = {Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series},
journal = {Turkish Journal of Internal Medicine},
year = {2022},
doi = {10.46310/tjim.1009709}
}
EUVIMED